172 related articles for article (PubMed ID: 6242017)
1. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
[TBL] [Abstract][Full Text] [Related]
2. [Immunohepatologic and clinical monitoring of neuramide therapy in acute viral hepatitis B].
Corridori S; Trespi G; Baldini E; Campisi D; Renzetti I; Calderon W
Boll Ist Sieroter Milan; 1985; 64(1):42-51. PubMed ID: 3159401
[TBL] [Abstract][Full Text] [Related]
3. [Selected indicators of hepatitis B in the blood serum during the first few days of hospitalization of patients with acute viral hepatitis].
Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
Ann Univ Mariae Curie Sklodowska Med; 1987; 42():83-7. PubMed ID: 3154900
[No Abstract] [Full Text] [Related]
4. Increase of OKT4+ cells during treatment with thymostimulin in parenteral drug addicts with persistent generalized lymphadenopathy.
Lazzarin A; Galli M; Moriondo P; Parravicini C; Poli G; Moroni M
J Clin Lab Immunol; 1986 Jun; 20(2):57-61. PubMed ID: 2942692
[TBL] [Abstract][Full Text] [Related]
5. Acute type B hepatitis in parenteral drug-addicts (PDA): prognostic value of circulating HBsAg/IgM complexes.
Caredda F; De Franchis R; D'Arminio Monforte A; Vecchi M; Antoniozzi F; Rossi E; Primignani M; Moroni M
Boll Ist Sieroter Milan; 1984; 63(6):496-8. PubMed ID: 6534395
[TBL] [Abstract][Full Text] [Related]
6. [Interferon therapy in chronic hepatitis B and delta infection in children].
Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
[No Abstract] [Full Text] [Related]
7. [Clinical aspects of severe forms of serum hepatitis type B].
Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
[No Abstract] [Full Text] [Related]
8. [Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis].
Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
Ann Univ Mariae Curie Sklodowska Med; 1987; 42():89-94. PubMed ID: 3154901
[No Abstract] [Full Text] [Related]
9. [Hepatic lesions in drug addiction].
Dal Monte PR; D'Imperio N; Formica G; Giuliani-Piccari G; Marzot G; Milandri G; Piemontese A; Ruggieri M; Sarti F; Spongano P
G Clin Med; 1981 Feb; 62(2):83-92. PubMed ID: 7239058
[No Abstract] [Full Text] [Related]
10. Thymostimulin in the treatment of hepatitis B surface antigen-positive chronic active hepatitis. Controlled clinical trial--two years follow-up.
Romeo F; Palmisano L; Arcoria D
Arzneimittelforschung; 1987 Apr; 37(4):450-6. PubMed ID: 3300664
[TBL] [Abstract][Full Text] [Related]
11. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
[No Abstract] [Full Text] [Related]
12. Viral hepatitis among prisoners in Norway.
Hurlen B; Siebke JC; Stensland A
NIPH Ann; 1980 Dec; 3(2):129-32. PubMed ID: 7219839
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial.
Romeo F; Arcoria D; Palmisano L; Polosa P
Arzneimittelforschung; 1985; 35(8):1317-22. PubMed ID: 3907642
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
[No Abstract] [Full Text] [Related]
16. [Leukinferon in the treatment of severe forms of acute hepatitis B].
Botsvadze ESh; Kuznetsov VP; Gogichaĭshvili ShSh
Ter Arkh; 1989; 61(11):50-4. PubMed ID: 2633393
[No Abstract] [Full Text] [Related]
17. What you need to know: interpreting hepatitis B viral markers.
Tan CK
Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
[No Abstract] [Full Text] [Related]
18. [Importance of the immune system in the symptom-free HBsAg carrier state].
Mansurov KhKh; Asfandiiarova NS
Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
[No Abstract] [Full Text] [Related]
19. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of epidemic delta infection in drug addicts.
Caredda F; d'Arminio Monforte A; Rossi E; Farci P; Smedile A; Tappero G; Moroni M
Prog Clin Biol Res; 1983; 143():245-50. PubMed ID: 6669581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
